Flagship Pioneering spinout thinks it has a treatment for 'long Covid'
October 26, 2021 at 07:00 AM EDT
In a near first for the biotech industry, Axcella Therapeutics Inc. is launching a clinical study investigating a new drug to treat "long Covid."
